WEDNESDAY, Sept. 16, 2020 (Healthday News) — A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization, the drug’s maker reported Wednesday. Eli Lilly’s announcement did not include detailed data and hasn’t been peer-reviewed orContinue Reading

WEDNESDAY, Sept. 16, 2020 (HealthDay News) — Most people now know that COVID-19 can cause blood clots, potentially leading to paralysis, stroke, heart attack and death. While it’s not clear precisely how SARS-CoV-2 causes clots, a new study suggests that the amount of a particular protein — called factor VContinue Reading

WEDNESDAY, Sept. 9, 2020 (Healthday News) — Final testing of a leading coronavirus vaccine candidate was paused by drugmaker AstraZeneca on Tuesday after a trial volunteer experienced a serious adverse reaction. The company did not release specifics on the case, but whether the reaction was caused by the vaccine orContinue Reading

FRIDAY, Sept. 4, 2020 (Healthday News) — The chief adviser for the White House vaccine program said Thursday it was “extremely unlikely, but not impossible” that a vaccine could be available by the end of October. Speaking with National Public Radio, Dr. Moncef Slaoui said that the U.S. Centers forContinue Reading